These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10483690)

  • 1. [Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens (Sabal fructus)].
    Schilcher H
    Wien Med Wochenschr; 1999; 149(8-10):236-40. PubMed ID: 10483690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia.
    Plosker GL; Brogden RN
    Drugs Aging; 1996 Nov; 9(5):379-95. PubMed ID: 8922564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serenoa repens for benign prostatic hyperplasia.
    Tacklind J; MacDonald R; Rutks I; Wilt TJ
    Cochrane Database Syst Rev; 2009 Apr; (2):CD001423. PubMed ID: 19370565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Mac Donald R
    Cochrane Database Syst Rev; 2002; (3):CD001423. PubMed ID: 12137626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms.
    Koch E
    Planta Med; 2001 Aug; 67(6):489-500. PubMed ID: 11509966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serenoa repens--the saw palmetto or dwarf palm].
    Swoboda H; Kopp B
    Wien Med Wochenschr; 1999; 149(8-10):235. PubMed ID: 10483689
    [No Abstract]   [Full Text] [Related]  

  • 7. Is there a scientific basis for the therapeutic effects of serenoa repens in benign prostatic hyperplasia? Mechanisms of action.
    Buck AC
    J Urol; 2004 Nov; 172(5 Pt 1):1792-9. PubMed ID: 15540722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saw palmetto and benign prostatic hyperplasia.
    Gong EM; Gerber GS
    Am J Chin Med; 2004; 32(3):331-8. PubMed ID: 15344416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia.
    Marks LS; Partin AW; Epstein JI; Tyler VE; Simon I; Macairan ML; Chan TL; Dorey FJ; Garris JB; Veltri RW; Santos PB; Stonebrook KA; deKernion JB
    J Urol; 2000 May; 163(5):1451-6. PubMed ID: 10751856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant extracts in BPH.
    Di Silverio F; Flammia GP; Sciarra A; Caponera M; Mauro M; Buscarini M; Tavani M; D'Eramo G
    Minerva Urol Nefrol; 1993 Dec; 45(4):143-9. PubMed ID: 7517582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of a lipido-sterolic extract of Serenoa repens in the management of lower urinary tract symptoms associated with benign prostatic hyperplasia.
    Gerber GS; Fitzpatrick JM
    BJU Int; 2004 Aug; 94(3):338-44. PubMed ID: 15291864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saw palmetto for prostate disorders.
    Gordon AE; Shaughnessy AF
    Am Fam Physician; 2003 Mar; 67(6):1281-3. PubMed ID: 12674456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexanic Extract of Serenoa repens (Permixon
    Blair HA
    Drugs Aging; 2022 Mar; 39(3):235-243. PubMed ID: 35237936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
    Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
    Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serenoa repens for benign prostatic hyperplasia.
    Wilt T; Ishani A; Stark G; MacDonald R; Mulrow C; Lau J
    Cochrane Database Syst Rev; 2000; (2):CD001423. PubMed ID: 10796790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The conservative treatment of early-stage benign prostatic hypertrophy].
    Kumanov Kh; Stoianova V; Lilov A; Kaloianov D
    Khirurgiia (Sofiia); 1993; 46(5):5-6. PubMed ID: 7527092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
    Grasso M; Montesano A; Buonaguidi A; Castelli M; Lania C; Rigatti P; Rocco F; Cesana BM; Borghi C
    Arch Esp Urol; 1995; 48(1):97-103. PubMed ID: 7537488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saw palmetto extract: newest (and oldest) treatment alternative for men with symptomatic benign prostatic hyperplasia.
    Marks LS; Tyler VE
    Urology; 1999 Mar; 53(3):457-61. PubMed ID: 10096366
    [No Abstract]   [Full Text] [Related]  

  • 19. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review.
    Wilt TJ; Ishani A; Stark G; MacDonald R; Lau J; Mulrow C
    JAMA; 1998 Nov; 280(18):1604-9. PubMed ID: 9820264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serenoa repens for Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: Current Evidence and Its Clinical Implications in Naturopathic Medicine.
    Ooi SL; Pak SC
    J Altern Complement Med; 2017 Aug; 23(8):599-606. PubMed ID: 28436684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.